Skip to main content
    A

    Akero Therapeutics Inc (AKRO)

    Official site

    BIOTECHNOLOGY

    $54.65
    +0.00 (+0.00%)

    Last updated: Dec 09, 2025 at 4:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    62%(16/26)
    Avg Surprise
    -16.93%
    PeriodReportedEst.SurpriseB/MYoY
    Sep 25
    Reported Nov 7
    		$-0.99$-0.93-6.19%Miss+5.7%
    Jun 25
    Reported Aug 8
    		$-0.86$-0.90+4.44%Beat-6.2%
    Mar 25
    Reported May 8
    		$-0.90$-0.99+9.25%Beat+0.0%
    Dec 24
    Reported Feb 26
    		$-0.99$-1.12+11.83%Beat+0.0%
    Sep 24
    Reported Nov 11
    		$-1.05$-0.90-16.67%Miss-47.9%
    Jun 24
    Reported Aug 9
    		$-0.81$-0.90+10.00%Beat-35.0%
    Mar 24
    Reported May 10
    		$-0.90$-0.95+5.26%Beat-63.6%
    Dec 23
    Reported Feb 29
    		$-0.99$-0.86-15.12%Miss-102.0%
    Sep 23
    Reported Nov 13
    		$-0.71$-0.68-4.41%Miss+22.8%
    Jun 23
    Reported Aug 11
    		$-0.60$-0.63+4.76%Beat+22.1%
    Mar 23
    Reported May 15
    		$-0.55$-0.67+17.91%Beat+25.7%
    Dec 22
    Reported Mar 17
    		$-0.49$-0.80+38.75%Beat+47.3%
    Sep 22
    Reported Nov 4
    		$-0.92$-0.74-24.32%Miss-31.4%
    Jun 22
    Reported Aug 4
    		$-0.77$-0.86+10.47%Beat+7.2%
    Mar 22
    Reported May 6
    		$-0.74$-0.80+7.50%Beat-72.1%
    Dec 21
    Reported Feb 25
    		$-0.93$-0.82-13.41%Miss-8.1%
    Sep 21
    Reported Nov 12
    		$-0.70$-0.91+23.08%Beat-11.1%
    Jun 21
    Reported Aug 13
    		$-0.83$-0.72-15.28%Miss-45.6%
    Mar 21
    Reported May 13
    		$-0.43N/A+52.75%Beat-2.4%
    Dec 20
    Reported Mar 16
    		$-0.86$-0.59-45.76%Miss-56.4%
    Sep 20
    Reported Nov 12
    		$-0.63$-0.65+3.08%Beat-12.5%
    Jun 20
    Reported Aug 12
    		$-0.57$-0.62+8.06%Beat+74.2%
    Mar 20
    Reported May 13
    		$-0.42$-0.61+31.15%Beat-85.6%
    Dec 19
    Reported Mar 16
    		$-0.55$-0.59+6.78%Beat+27.6%
    Sep 19
    Reported Nov 12
    		$-0.56$-0.43-30.23%Miss-
    Jun 19
    Reported Aug 12
    		$-2.21$-0.36-513.89%Miss-
    Mar 19
    Reported Jun 20
    		$-0.23$0.00N/AMiss-
    Dec 18
    Reported Jan 17
    		$-0.76$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$54.52
    SMA 20$54.40
    SMA 50$53.06
    SMA 200N/A
    EMA 10$54.53
    EMA 20$54.31
    EMA 50$52.95
    EMA 200$48.08

    MACD

    Line: 0.42Signal: 0.52Hist: -0.10

    ADX

    ADX: 35.8+DI: 28.7-DI: 14.6

    Aroon & PSAR

    Aroon Up96.0
    Aroon Down12.0
    PSAR$54.31

    Bollinger Bands

    Upper Band$54.71
    Lower Band$54.10
    %B Position112%(Upper)
    Band Width0.90

    RSI (14-Day)

    Neutral
    69.2

    Momentum Oscillators

    Stoch %K70.2
    Stoch %D76.9
    Williams %R-28.9
    ROC (10d)0.5%
    Momentum0.29
    CCI (20d)151.4
    MFI (14d)84.2

    Volatility Measures

    ATR (14d)$0.27(0.5%)
    StdDev (20d)0.15
    Hist Vol2.3%(Low)

    Volume Flow

    VWAP$54.65
    OBV54.8M
    AD Line-22.8M
    CMF (20d)0.226

    Volume Metrics

    Avg Vol (20d)2.3M
    Vol RatioN/A
    VWMA (20d)$54.50

    Pivot Points

    R3$55.31
    R2$55.07
    R1$54.86
    Pivot Point$54.62
    S1$54.41
    S2$54.16
    S3$53.95

    Advanced Oscillators

    TSI38.66
    Ultimate Osc66.2
    KST17.96

    Financial Data

    QuarterSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Total Revenue$0$0$0$4,000$0$0$0$284,000$0$0$0$0
    Cost of Revenue$0$0$0$2,000$0$0$0$2,000$0$0$0$65,000
    Gross Profit$0$0$0$2,000$0$0$0$-2,000$0$0$0$-65,000
    Operating Expenses$90.24M$80.87M$80.88M$78.03M$81.70M$65.74M$59.95M$61.87M$46.62M$35.63M$28.75M$25.42M
    R&D$78.88M$69.25M$69.57M$69.29M$72.23M$55.32M$50.65M$53.39M$38.63M$27.98M$21.79M$18.32M
    SG&A$11.35M$11.62M$11.31M$8.73M$9.47M$10.42M$9.30M$8.48M$7.98M$7.64M$6.97M$7.10M
    Operating Income$-90,236,000$-80,873,000$-80,882,000$-78,025,000$-81,703,000$-65,741,000$-59,954,000$-61,873,000$-46,615,000$-35,629,000$-28,753,000$-25,420,000
    Interest Income$11.32M$11.54M$11.31M$9.20M$10.24M$10.98M$7.60M$7.58M$7.84M$5.40M$3.38M$0
    Interest Expense$2.65M$1.17M$1.15M$1.20M$1.25M$1.23M$991,000$897,000$888,000$857,000$457,000$362,000
    Income Before Tax$-81,566,000$-70,505,000$-70,725,000$-70,024,000$-72,705,000$-55,987,000$-53,344,000$-55,186,000$-39,659,000$-31,083,000$-25,831,000$-21,920,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-81,566,000$-70,505,000$-70,725,000$-70,024,000$-72,705,000$-55,987,000$-53,344,000$-55,186,000$-39,659,000$-31,083,000$-25,831,000$-23,059,000
    EBITDA$-92,486,000$-83,547,000$-83,167,000$-80,848,000$-85,275,000$-69,030,000$-62,763,000$-65,397,000$-49,763,000$-36,877,000$-29,910,000$-25,510,000
    EBIT$-90,236,000$-80,873,000$-80,882,000$-78,025,000$-81,703,000$-65,741,000$-59,954,000$-61,873,000$-46,615,000$-35,629,000$-28,753,000$-25,420,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about AKRO

    News

    No news available

    Company news will appear here when available

    AKRO Competitors

    CompanyTicker
    Amicus Therapeutics IncFOLD
    Diversified Healthcare TrustDHCNL
    Option Care Health IncOPCH
    Integer Holdings CorpITGR
    Lifestance Health Group IncLFST
    Heartflow, Inc. Common StockHTFL
    Concentra Group Holdings Parent, Inc.CON
    LivaNova PLCLIVN

    Sector: Healthcare

    AKRO Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    0.4%

    Frequently Asked Questions About AKRO

    Does AKRO pay dividends?

    Akero Therapeutics Inc (AKRO) does not currently pay a regular dividend.

    Related stocks

    Sector: Healthcare

    All stocks starting with A

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In